Want to see AFIB full AI Analyst Report?
Acutus Medical (AFIB) Ratios
Acutus Medical Ratios
AFIB's free cash flow for Q4 2024 was $-4.02M. For the 2024 fiscal year, AFIB's free cash flow was increased by $36.00K and operating cash flow was $-4.06M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.06 | 2.44 | 5.93 | 6.82 | 6.91 |
| Quick Ratio | 1.91 | 2.22 | 5.26 | 5.94 | 6.32 |
| Cash Ratio | 1.13 | 1.01 | 1.29 | 1.30 | 1.15 |
| Solvency Ratio | -0.21 | -1.47 | -0.66 | -1.73 | -1.49 |
| Operating Cash Flow Ratio | -2.55 | -3.33 | -4.28 | -5.39 | -3.89 |
| Short-Term Operating Cash Flow Coverage | -4.52 | -33.86 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -14.66M | $ -8.59M | $ 59.45M | $ 62.22M | $ 85.44M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.25 | 0.71 | 0.29 | 0.27 | 0.21 |
| Debt-to-Equity Ratio | -3.09 | -43.78 | 0.52 | 0.43 | 0.32 |
| Debt-to-Capital Ratio | 1.48 | 1.02 | 0.34 | 0.30 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 1.83 | 1.03 | 0.31 | 0.28 | 0.24 |
| Financial Leverage Ratio | -2.47 | -61.39 | 1.78 | 1.61 | 1.52 |
| Debt Service Coverage Ratio | 0.18 | -0.72 | 6.83 | -18.52 | -16.81 |
| Interest Coverage Ratio | -0.01 | -2.54 | -4.46 | -20.41 | -16.59 |
| Debt to Market Cap | 19.89 | 5.88 | 1.05 | 0.41 | 0.12 |
| Interest Debt Per Share | 1.39 | 1.52 | 1.55 | 1.78 | 4.08 |
| Net Debt to EBITDA | 9.67 | -3.62 | 0.38 | -0.20 | -0.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 5.03% | -43.79% | -63.02% | -90.73% | -87.72% |
| EBIT Margin | 6.06% | -86.59% | 1121.64% | -648.82% | -1139.56% |
| EBITDA Margin | 11.16% | -74.39% | 1161.50% | -608.91% | -1093.43% |
| Operating Profit Margin | -0.28% | -200.46% | -757.90% | -671.19% | -1079.08% |
| Pretax Profit Margin | -22.50% | -165.52% | 951.77% | -681.71% | -1204.61% |
| Net Profit Margin | -47.36% | -1139.91% | -1307.03% | -681.71% | -1204.88% |
| Continuous Operations Profit Margin | -22.50% | -166.40% | 951.27% | -681.71% | -1204.88% |
| Net Income Per EBT | 210.47% | 688.67% | -137.33% | 100.00% | 100.02% |
| EBT Per EBIT | 7957.89% | 82.57% | -125.58% | 101.57% | 111.63% |
| Return on Assets (ROA) | -33.33% | -151.34% | -29.69% | -69.31% | -52.97% |
| Return on Equity (ROE) | 82.36% | 9290.44% | -52.81% | -111.31% | -80.56% |
| Return on Capital Employed (ROCE) | -0.35% | -41.01% | -20.23% | -76.59% | -53.53% |
| Return on Invested Capital (ROIC) | -0.24% | -38.19% | -20.16% | -76.39% | -53.24% |
| Return on Tangible Assets | -33.33% | -151.34% | -30.04% | -77.04% | -58.32% |
| Earnings Yield | -583.11% | -1390.16% | -120.99% | -120.44% | -31.03% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.56 | 0.63 | 0.13 | 4.75 | 3.92 |
| Payables Turnover | 15.00 | 3.73 | 12.90 | 4.38 | 1.92 |
| Inventory Turnover | 10.69 | 2.41 | 2.39 | 2.01 | 1.23 |
| Fixed Asset Turnover | 6.77 | 1.78 | 0.23 | 0.95 | 0.60 |
| Asset Turnover | 0.70 | 0.13 | 0.02 | 0.10 | 0.04 |
| Working Capital Turnover Ratio | 1.00 | 0.11 | 0.03 | 0.15 | 0.09 |
| Cash Conversion Cycle | 152.45 | 632.18 | 2848.35 | 175.36 | 200.93 |
| Days of Sales Outstanding | 142.65 | 578.43 | 2724.19 | 76.81 | 93.15 |
| Days of Inventory Outstanding | 34.13 | 151.58 | 152.44 | 181.90 | 297.67 |
| Days of Payables Outstanding | 24.33 | 97.83 | 28.29 | 83.35 | 189.89 |
| Operating Cycle | 176.78 | 730.01 | 2876.63 | 258.71 | 390.82 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.06 | -2.17 | -2.99 | -3.48 | -7.47 |
| Free Cash Flow Per Share | -1.07 | -2.18 | -3.13 | -3.83 | -8.45 |
| Dividend Paid and CapEx Coverage Ratio | -282.68 | -288.21 | -21.35 | -10.00 | -7.59 |
| Capital Expenditure Coverage Ratio | -282.68 | -288.21 | -21.35 | -10.00 | -7.59 |
| Operating Cash Flow Coverage Ratio | -0.89 | -1.64 | -2.19 | -2.20 | -2.07 |
| Operating Cash Flow to Sales Ratio | -1.57 | -8.81 | -28.05 | -5.77 | -10.06 |
| Free Cash Flow Yield | -1940.57% | -1078.20% | -271.87% | -112.22% | -29.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.17 | -0.07 | -0.83 | -0.83 | -3.22 |
| Price-to-Sales (P/S) Ratio | 0.08 | 0.82 | 10.80 | 5.66 | 38.83 |
| Price-to-Book (P/B) Ratio | -0.14 | -6.68 | 0.44 | 0.92 | 2.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.05 | -0.09 | -0.37 | -0.89 | -3.41 |
| Price-to-Operating Cash Flow Ratio | -0.05 | -0.09 | -0.39 | -0.98 | -3.86 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 0.01 | 0.02 | -0.02 |
| Enterprise Value Multiple | 10.40 | -4.73 | 1.31 | -1.13 | -3.72 |
| Enterprise Value | 23.38M | 25.18M | 46.01M | 119.04M | 344.50M |
| EV to EBITDA | 10.40 | -4.73 | 1.31 | -1.13 | -3.72 |
| EV to Sales | 1.16 | 3.52 | 15.18 | 6.90 | 40.70 |
| EV to Free Cash Flow | -0.74 | -0.40 | -0.52 | -1.09 | -3.57 |
| EV to Operating Cash Flow | -0.74 | -0.40 | -0.54 | -1.19 | -4.04 |
| Tangible Book Value Per Share | -0.39 | -0.03 | 2.58 | 3.10 | 9.55 |
| Shareholders’ Equity Per Share | -0.39 | -0.03 | 2.63 | 3.69 | 11.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.01 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.68 | 0.25 | 0.11 | 0.60 | 0.74 |
| Net Income Per Share | -0.32 | -2.81 | -1.39 | -4.11 | -8.94 |
| Tax Burden | 2.10 | 6.89 | -1.37 | 1.00 | 1.00 |
| Interest Burden | -3.71 | 1.91 | 0.85 | 1.05 | 1.06 |
| Research & Development to Revenue | 0.00 | 0.49 | 9.29 | 2.12 | 3.95 |
| SG&A to Revenue | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.42 | 1.12 | 0.80 | 1.43 |
| Income Quality | 6.98 | 1.59 | 2.15 | 0.85 | 0.84 |
Currency in USD